Immuno-based retargeted endopeptidase activity assays
Abstract:
The present specification discloses a retargeted endopeptidase pharmaceutical wherein the activity has been determined by the methods disclosed.
Public/Granted literature
Information query
Patent Agency Ranking
0/0